Literature DB >> 11918652

Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain.

Weiya Ma1, James C Eisenach.   

Abstract

Inflammatory mediators produced in the injured nerve have been proposed as contributing factors in the development of neuropathic pain. Prostaglandins (PGs) are probably included in these important inflammatory mediators. In the present study, 2 and 4 weeks following partial sciatic nerve ligation (PSNL), we observed a dramatic increase in the prostaglandin synthesizing enzyme cyclooxygenase (COX)2-immunoreactive (IR) cell profiles in the injury site and adjacent region. Some of these COX2-IR cells were identified as macrophages because they coexpressed ED1. None of these COX2-IR cell profiles coexpressed the Schwann cell marker S100. In the contralateral sciatic nerve and sciatic nerve from normal rats, we failed to observe any of these COX-IR cell profiles. We also observed COX1-IR cell profiles (presumably Langerhans cells) in the epidermis of the footpad of both normal and PSNL rats. Interestingly, a greater number of COX1-IR cell profiles were observed in the epidermis of the ipsilateral footpad of PSNL rats. Local injection of ketorolac, a nonselective COX inhibitor, into the ipsilateral plantar side or into the injury site of the sciatic nerve, effectively reversed the tactile allodynia induced by PSNL for > 5 days. Intraperitoneal or intramuscular injection of ketorolac had a similar but shorter antiallodynic effect. Intraplantar or peri-neural injection of ketorolac dramatically suppressed the PSNL-induced increase in the phosphorylation of a transcription factor cAMP response element binding protein (CREB) in the ipsilateral dorsal horn of L4 and L5 spinal cord of PSNL rats. Intraplantar or peri-neural injection of ketorolac at the time of lesion did not prevent mechanical hypersensitivity but reduced it with a slow onset 3 weeks after lesion. Our data suggest that PSNL induces over-production of PGs in peripheral tissues and that PGs probably sensitize nociceptors and are involved in central plasticity and sensitization at the spinal cord level, thus contributing to the maintenance of tactile allodynia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918652     DOI: 10.1046/j.1460-9568.2002.01940.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  25 in total

1.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.

Authors:  Flobert Y Tanga; Nancy Nutile-McMenemy; Joyce A DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

2.  The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.

Authors:  Elsa-Marie Treutlein; Katharina Kern; Andreas Weigert; Neda Tarighi; Claus-Dieter Schuh; Rolf M Nüsing; Yannick Schreiber; Nerea Ferreirós; Bernhard Brüne; Gerd Geisslinger; Sandra Pierre; Klaus Scholich
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

Review 3.  Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.

Authors:  Allyson J Ocean; Linda T Vahdat
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

4.  Localization of COX-1 and COX-2 in the intracranial dura mater of the rat.

Authors:  Xi-Chun Zhang; Vanessa Kainz; Moshe Jakubowski; Rami Burstein; Andrew Strassman; Dan Levy
Journal:  Neurosci Lett       Date:  2009-03-06       Impact factor: 3.046

5.  Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain.

Authors:  B Costa; M Colleoni; S Conti; A E Trovato; M Bianchi; M L Sotgiu; G Giagnoni
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

6.  The effect of preoperative ketorolac on WBC response and pain in laparoscopic surgery for endometriosis.

Authors:  Jeong-Yeon Hong
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

7.  Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.

Authors:  Mohab M Ibrahim; Hongfeng Deng; Alexander Zvonok; Debra A Cockayne; Joyce Kwan; Heriberto P Mata; Todd W Vanderah; Josephine Lai; Frank Porreca; Alexandros Makriyannis; T Philip Malan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

8.  Ketorolac reduces spinal astrocytic activation and PAR1 expression associated with attenuation of pain after facet joint injury.

Authors:  Ling Dong; Jenell R Smith; Beth A Winkelstein
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

9.  Controlled release of GDNF reduces nerve root-mediated behavioral hypersensitivity.

Authors:  Raymond D Hubbard; Joan J Martínez; Jason A Burdick; Beth A Winkelstein
Journal:  J Orthop Res       Date:  2009-01       Impact factor: 3.494

10.  An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat.

Authors:  Christopher M Peters; Juan Miguel Jimenez-Andrade; Michael A Kuskowski; Joseph R Ghilardi; Patrick W Mantyh
Journal:  Brain Res       Date:  2007-07-17       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.